A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM. Frontiers in Immunology, 2022; 13 DOI: 10.3389/fimmu.2022.1044743 ...

Nephritis, clinical trials and biomarkers rank highest among research priorities related to childhood-onset systematic lupus erythematosus, according to a survey of rheumatologists, dermatologists ...

Access free, up-to-date clinical references on the pathogenesis and pathophysiology of Lupus at Healio. We aid in making confident point-of-care decisions.

Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of lupus nephritis.

Updated Lupus Nephritis Guideline Advises First-Line Triple Therapy Tara Haelle November 28, 2024 0 ...

Nephritis is an inflammation of the nephrons, which are part of the kidneys. Also known as glomerulonephritis, it can affect kidney function, leading to changes in urine and urination habits and ...

How do you monitor patients with lupus nephritis for disease progression and treatment response? (Dr. Larranaga) Three-year follow-up results of voclosporin from the AURORA-2 study were published ...

Obinutuzumab plus standard of care (SOC) treatment may slow kidney function decline and reduce flares in patients with class 3 or 4 lupus nephritis, investigators suggest. In a post hoc analysis ...

Researchers from Johns Hopkins Medicine and Yale University have collaborated on the development and application of a diagnostic model to detect acute interstitial nephritis (AIN) in patients ...

“Dosing the first lupus nephritis patient in our Phase 1 trial of ADI-001 marks an important step forward in our mission of improving the lives of patients affected by autoimmune diseases ...

PRESS RELEASE GlobeNewswire Jun. 16, 2020, 08:44 AM Dublin, June 16, 2020 (GLOBE NEWSWIRE) -- The "Systemic Lupus Erythematosus and Lupus Nephritis: Global Drug Forecast and Market Analysis to ...